The British Pharmacopoeia on Monday released its response to its consultation on dissolution testing and announced its plans to update its approach within its product monographs. The British ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining Agilent instrumentation ...
The dissolution profile of inhaled drugs underpins therapeutic efficacy and is an area of increasing regulatory scrutiny, particularly for the demonstration of bioequivalence in a generic. The new ...
Teva is voluntarily recalling a single lot of Anagrelide Capsules, USP 0.5mg, due to dissolution failure that was detected during a routine stability test. Teva is voluntarily recalling a single lot ...
Torrent Pharmaceuticals Limited is voluntarily recalling one lot of Anagrelide Capsules, USP to the consumer level due to dissolution test failure detected during routine quality testing.
Join host Neil Lander on Chromatography Life as he interviews Ben Calvopina, Application Scientist and expert in dissolution testing at SOTAX. Ben shares his journey from service engineering to ...
The 13th Annual International Symposium on Dissolution Science and Applications – DISSO INDIA 2025, organized by the Society for Pharmaceutical Dissolution Science (SPDS), in collaboration with SVKM's ...
The Kathmandu Post on MSN
DDA took 11 months to test substandard drug. Patients may have already taken it
The Department of Drug Administration (DDA) has recalled a third-generation antibiotic, Levoflox-500 tablet, after the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback